paroxetine has been researched along with Stress Disorders, Post-Traumatic in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (7.41) | 18.2507 |
| 2000's | 34 (41.98) | 29.6817 |
| 2010's | 28 (34.57) | 24.3611 |
| 2020's | 13 (16.05) | 2.80 |
| Authors | Studies |
|---|---|
| Brunet, A; Guragain, B; Kirmayer, LJ; Sapkota, RP; Saumier, D; Tremblay, J | 1 |
| Barbui, C; Bertolini, F; Bisson, JI; Churchill, R; Meader, N; Ostuzzi, G; Robertson, L; Stein, DJ; Williams, T | 1 |
| Ipser, JC; Phillips, NJ; Stein, DJ; Williams, T | 1 |
| Condiotte, A; Govada, V | 1 |
| Gasparyan, A; Manzanares, J; Navarrete, F; Navarro, D | 1 |
| Li, XZ; Liu, JL; Liu, RB; Xian-Yu, CY; Zhang, C; Zhang, J; Zhang, YQ; Zhang, ZX | 1 |
| Nasrallah, HA; Sagarwala, R | 1 |
| Garabadu, D; Krishnamurthy, S; Prajapati, SK; Singh, N | 1 |
| Baker, A; Bisson, JI; Dekker, W; Hoskins, MD | 1 |
| de Moraes Costa, G; Mello, CF; Soares Barros, AJ; Zanatta, FB; Ziegelmann, PK | 1 |
| Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
| Krishnamurthy, S; Prajapati, SK | 1 |
| Albrechtsen, A; Buller, R; Eriksson, H; Hobart, M; Lindgreen, S; Moltke, I; Nøhr, AK | 1 |
| Bhattacharjee, A; Krishnamurthy, S; Prajapati, SK | 1 |
| Gui, J; Maguen, S; Schnurr, PP; Shiner, B; Watts, BV; Westgate, CL; Young-Xu, Y | 1 |
| Borrelli, J; Downs, DL; North, CS; Starr, A | 1 |
| Franc, B; Lanfumey, L; Martin, V; Mongeau, R; Poilbout, C; Règue, M | 1 |
| Cinconze, M; Concerto, C; Costanzo, MC; Signorelli, MS | 1 |
| Fellous, JM; Krahl, SE; Langevin, JP; Stidd, DA; Vogelsang, K | 1 |
| Garabadu, D; Joy, KP; Krishnamurthy, S | 1 |
| Gupta, MA | 1 |
| Beeské, S; Belzung, C; Griebel, G; Philbert, J | 1 |
| Cui, H; Gong, Q; Huang, X; Li, T; Lui, S; Meng, Y; Qiu, C; Zhang, J; Zhang, W; Zhang, Y; Zhu, H | 1 |
| Bennis, M; Bentefour, Y; Garcia, R; M'hamed, SB | 1 |
| Akindipe, TO; Ipser, JC; Sager, C; Stein, DJ; Wilson, D | 1 |
| Popiel, A; Pragłowska, E; Teichman, Y; Zawadzki, B | 1 |
| Ahmad, A; Garabadu, D; Krishnamurthy, S | 1 |
| Fitzgerald, DA; Kennedy, AE; Liberzon, I; MacNamara, A; Phan, KL; Rabinak, CA; Stein, MB | 1 |
| Furukawa, T; Migita, K; Nakashima, T; Nikaido, Y; Shiba, Y; Ueno, S; Yamada, J | 1 |
| Ba-M'hamed, S; Bennis, M; Bentefour, Y; Garcia, R; Rakibi, Y | 1 |
| Conti, AC; Eagle, AL; Galloway, MP; George, SA; Gerard, J; Ghoddoussi, F; Harutyunyan, A; Hool, SM; Kohler, RJ; Liberzon, I; Mulo, K; Perrine, SA; Schneider, BL; Susick, LL | 1 |
| Arai, A; Hirota, Y; Mitsui, S; Miyase, N; Miyata, S; Osako, Y; Young, LJ; Yuri, K | 1 |
| Cui, H; Li, Y; Qiu, C; Tang, X; Zhang, W; Zhang, Y; Zhu, H | 1 |
| Chen, YC; Jin, X; Liu, Y; Luo, XX; Tan, QR; Wang, HN; Wang, W; Zheng, H; Zheng, LN | 1 |
| Freeman, MP | 1 |
| Dotan, Y; Pillar, G; Suraiya, S | 1 |
| Asukai, N; Hirotsune, H; Inoue, H; Iwasaki, M; Kato, H; Kim, Y; Konishi, T; Maeda, M; Narita, H | 1 |
| Afzal, N; Ashraf, A; Bremner, JD; Fani, N; Jawed, F; Kitayama, N; Reed, L | 2 |
| Fuchikami, M; Liberzon, I; Matsuki, A; Morinobu, S; Takei, S; Yamamoto, S; Yamawaki, S | 1 |
| Garner, B; Hetrick, SE; Parslow, R; Purcell, R | 1 |
| Alesci, S; Bonne, O; Charney, DS; Collins, C; Gill, JM; Kinkead, B; Luckenbaugh, DA; Manji, HK; Neumeister, A; Owens, MJ; Vythilingam, M; Yuan, P | 1 |
| Amsel, L; Hembree, E; Marshall, RD; Neria, Y; Pavlicova, M; Schneier, FR; Suh, EJ | 1 |
| He, B; Qiao, F; Wang, H; Wu, Y; Zhao, M; Zuo, D | 1 |
| Denys, D; Figee, M; Olff, M; Opmeer, BC; Polak, AR; Visser, RS; Vulink, N; Witteveen, AB | 1 |
| Bradford, DW; Connor, KM; Davidson, JR; Dolber, TR; Kilts, JD; Marx, CE; Naylor, JC; Strauman, TJ; Strauss, JL; Szabo, ST; Youssef, NA | 1 |
| Fazel, M; Goldring, L; Reed, RV | 1 |
| Green, B | 1 |
| Bremner, JD; Charney, DS; Southwick, SM; Vermetten, E; Vythilingam, M | 1 |
| Beebe, K; Davidson, J; Seedat, S; Stein, DJ | 1 |
| Davidson, JR | 3 |
| Nibuya, M; Nomura, S; Sawamura, T; Shimizu, K; Suzuki, G; Takahashi, Y; Tsunoda, T; Wakizono, T | 1 |
| Beebe, KL; Burgin, C; Masters, BK; Nawar, O; Parker, DE; Tucker, P; Wyatt, DB | 1 |
| Ballenger, JC | 1 |
| Nakai, K; Nibuya, M; Nomura, S; Sawamura, T; Shimizu, K; Takahashi, Y | 1 |
| Bremner, JD; Vermetten, E | 1 |
| Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Martényi, F | 1 |
| Bremner, JD; Foa, EB; Mayberg, HS; Nemeroff, CB; North, CS; Stein, MB | 1 |
| Hensley, PL | 1 |
| Bour, LJ; Cupido, C; de Vries, GJ; Koelman, JH; Olff, M; Raabe, S; Siegelaar, SE; Tijssen, MA; van Bruggen, G; Veelo, D; Zwinderman, AH | 1 |
| Kikuchi, A; Nibuya, M; Sawamura, T; Shimizu, K; Soichiro, N; Suzuki, G; Takahashi, Y; Toda, H; Wakizono, T | 1 |
| Bremner, JD; Charney, DS; DE Kloet, C; Schmahl, C; Southwick, SM; Vermetten, E; Vythilingam, M | 1 |
| Blanco, C; Garcia, W; Lewis-Fernandez, R; Liebowitz, MR; Lin, SH; Marshall, RD; Neria, Y; Sanchez-Lacay, A; Schneier, F; Simpson, HB; Vermes, D | 1 |
| Iwamoto, Y; Morinobu, S; Takahashi, T; Yamawaki, S | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Bravo-Mehmedbasić, A; Dzubur-Kulenović, A; Kucukalić, A | 1 |
| Connor, KM; Davidson, JR; Foa, EB; Krulewicz, S; Lang, AJ; LeBeau, RT; Otto, MW; Pollack, MH; Rauch, S; Simon, NM; Stein, MB | 1 |
| Arora, RC; Crayton, JW; Fichtner, CG; O'Connor, FL | 1 |
| Arora, RC; Crayton, JW; Fichtner, CG; O'Connor, F | 1 |
| Abbate, LA; Campeas, R; Fallon, BA; Goetz, D; Knight, CB; Liebowitz, MR; Marshall, RD; Schneier, FR | 1 |
| Houck, PR; Jacobs, S; Miller, MD; Prigerson, HG; Reynolds, CF; Shear, MK; Zygmont, M | 1 |
| Delmeire, L; Lin, AH; Maes, M; Scharpé, S; Van der Planken, M; Van Gastel, A; Verkerk, R | 1 |
| Connor, KM; Davidson, JR | 1 |
| Agid, O; Lerer, B; Shalev, AY | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Beebe, KL; Marshall, RD; Oldham, M; Zaninelli, R | 1 |
| Dillingham, K; Pitts, CD; Ruggiero, L; Tucker, P; Yehuda, R; Zaninelli, R | 1 |
| Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
22 review(s) available for paroxetine and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD).
Topics: Adult; Humans; Hydrocortisone; Paroxetine; Psychotherapy; Quality of Life; Stress Disorders, Post-Traumatic | 2022 |
Pharmacotherapy for post traumatic stress disorder (PTSD).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Humans; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Young Adult | 2022 |
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies.
Topics: Animals; Anxiety Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2022 |
Clinical outcomes of recommended active pharmacotherapy agents from NICE guideline for post-traumatic stress disorder: Network meta-analysis.
Topics: Cognitive Behavioral Therapy; Humans; Network Meta-Analysis; Paroxetine; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2023 |
Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
Topics: Biomarkers; Humans; Hydrocortisone; Inflammation; Interleukin-1beta; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2019 |
Pharmacological treatments for adults with post-traumatic stress disorder: A network meta-analysis of comparative efficacy and acceptability.
Topics: Adult; Humans; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Topics: Alcohol-Related Disorders; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Desipramine; Humans; Paroxetine; Phobia, Social; Publication Bias; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2015 |
Single prolonged stress: toward an animal model of posttraumatic stress disorder.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Arousal; Brain; Conditioning, Classical; Cycloserine; Disease Models, Animal; Extinction, Psychological; Fear; Glucocorticoids; Humans; Mental Recall; Paroxetine; Rats; Stress Disorders, Post-Traumatic | 2009 |
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).
Topics: Adolescent; Adult; Child; Child Abuse, Sexual; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2010 |
[Posttraumatic stress disorder].
Topics: Adolescent; Adult; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Cultural Comparison; Cross-Sectional Studies; Diagnosis, Differential; Eye Movement Desensitization Reprocessing; Female; Guideline Adherence; Humans; Life Change Events; Male; Mianserin; Mirtazapine; Paroxetine; Stress Disorders, Post-Traumatic | 2013 |
Focus on paroxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.
Topics: Administration, Oral; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2003 |
Treatment of posttraumatic stress disorder: the impact of paroxetine.
Topics: Antidepressive Agents, Second-Generation; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2003 |
Remission rates in patients with anxiety disorders treated with paroxetine.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2004 |
[An animal model of posttraumatic stress disorder and its validity: effect of paroxetine on a PTSD model in rats].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2004 |
[Posttraumatic stress disorder (PTSD)].
Topics: Antidepressive Agents, Second-Generation; Catecholamines; Comorbidity; Controlled Clinical Trials as Topic; Crime Victims; Female; Humans; Hypothalamo-Hypophyseal System; Incidence; Life Change Events; Male; Paroxetine; Pituitary-Adrenal System; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans Disability Claims; Vietnam Conflict; World War I; World War II | 2004 |
Posttraumatic stress disorder: a state-of-the-science review.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cross-Sectional Studies; Depressive Disorder; Hippocampus; Humans; Life Change Events; Paroxetine; Risk Factors; Stress Disorders, Post-Traumatic | 2006 |
Treatment of bereavement-related depression and traumatic grief.
Topics: Antidepressive Agents, Tricyclic; Bereavement; Depressive Disorder, Major; Humans; Nortriptyline; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2006 |
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
Topics: Algorithms; Anxiety Disorders; Comorbidity; Depressive Disorder; Disasters; Drug Administration Schedule; Humans; Internet; Paroxetine; Psychotropic Drugs; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Survivors; Treatment Outcome | 2006 |
[An animal model of posttraumatic stress disorder in rats using a shuttle box].
Topics: Animals; Disease Models, Animal; Male; Paroxetine; Rats; Rats, Inbred F344; Rats, Wistar; Stress Disorders, Post-Traumatic | 2006 |
Management of posttraumatic stress disorder: diagnostic and therapeutic issues.
Topics: Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Depressive Disorder; Diagnosis, Differential; Humans; Life Change Events; Paroxetine; Psychotherapy; Psychotropic Drugs; Stress Disorders, Post-Traumatic; Substance-Related Disorders | 1999 |
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Fluoxetine; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles | 2000 |
23 trial(s) available for paroxetine and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
Tackling the global problem of traumatic stress in low-income countries: a pilot clinical trial comparing reconsolidation therapy to paroxetine in Nepal.
Topics: Adult; Humans; Nepal; Paroxetine; Poverty; Stress Disorders, Post-Traumatic; Treatment Outcome | 2021 |
Predictors and trajectories of treatment response to SSRIs in patients suffering from PTSD.
Topics: Anxiety; Anxiety Disorders; Child; Double-Blind Method; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2021 |
Altered spontaneous neuronal activity in chronic posttraumatic stress disorder patients before and after a 12-week paroxetine treatment.
Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Disasters; Earthquakes; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Paroxetine; Stress Disorders, Post-Traumatic; Treatment Outcome; Visual Cortex | 2015 |
Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - The "TRAKT" study.
Topics: Accidents, Traffic; Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Implosive Therapy; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2015 |
Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience.
Topics: Adult; Cluster Analysis; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2008 |
Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2009 |
Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study.
Topics: Adult; Cerebral Cortex; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Male; Paroxetine; Pilot Projects; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2011 |
Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.
Topics: Combined Modality Therapy; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Middle Aged; New York City; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; September 11 Terrorist Attacks; Stress Disorders, Post-Traumatic; Treatment Outcome | 2012 |
Comparison of the effectiveness of trauma-focused cognitive behavioral therapy and paroxetine treatment in PTSD patients: design of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Humans; Middle Aged; Paroxetine; Research Design; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2012 |
A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.
Topics: Adult; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2013 |
Paroxetine treatment of depression with posttraumatic stress disorder: effects on autonomic reactivity and cortisol secretion.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Neurosecretory Systems; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Stress Disorders, Post-Traumatic; Treatment Outcome | 2004 |
Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Data Interpretation, Statistical; Double-Blind Method; Female; Heart Rate; Humans; Hydrocortisone; Paroxetine; Psychiatric Status Rating Scales; Saliva; Stress Disorders, Post-Traumatic; Stress, Psychological | 2006 |
A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Black People; Chronic Disease; Dissociative Disorders; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Interpersonal Relations; Male; Middle Aged; Paroxetine; Personality Assessment; Stress Disorders, Post-Traumatic; Urban Population; White People | 2007 |
Paroxetine in the treatment of post traumatic stress disorder: our experiences.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Dose-Response Relationship, Drug; Health Surveys; Humans; Outcome Assessment, Health Care; Paranoid Disorders; Paroxetine; Phobic Disorders; Stress Disorders, Post-Traumatic; Treatment Outcome | 2008 |
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
Topics: Cognitive Behavioral Therapy; Combined Modality Therapy; Delayed-Action Preparations; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2008 |
Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response.
Topics: Adult; Blood Platelets; Drug Interactions; Fluoxetine; Humans; Kinetics; Male; Middle Aged; Paroxetine; Stress Disorders, Post-Traumatic; Tritium | 1994 |
An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 1998 |
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief.
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Female; Grief; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 1998 |
Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression.
Topics: Adrenergic alpha-Antagonists; Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Male; Middle Aged; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic; Tyrosine; Yohimbine | 1999 |
Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.
Topics: Adult; Ambulatory Care; Depression; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Triiodothyronine | 2001 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Assessment; Sex Factors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2001 |
Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Topics: Adolescent; Adult; Aged; Chronic Disease; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2001 |
36 other study(ies) available for paroxetine and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
Attempted "Suicide by Police" by a Patient With Bipolar I Disorder and PTSD on Paroxetine Monotherapy.
Topics: Bipolar Disorder; Humans; Paroxetine; Police; Stress Disorders, Post-Traumatic; Suicide, Attempted | 2022 |
A novel stress re-stress model: modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats.
Topics: Animals; Anxiety; Behavior, Animal; Cognitive Dysfunction; Corticosterone; Cues; Depression; Disease Models, Animal; Electric Stimulation; Hypothalamo-Hypophyseal System; Male; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2020 |
Evidence-based prescribing for post-traumatic stress disorder.
Topics: Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |
Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses.
Topics: Amygdala; Animals; Azepines; Corticosterone; Disease Models, Animal; Male; Orexin Receptor Antagonists; Orexins; Paroxetine; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic; Triazoles | 2021 |
Supplementation of taurine improves ionic homeostasis and mitochondrial function in the rats exhibiting post-traumatic stress disorder-like symptoms.
Topics: Animals; Corticosterone; Maze Learning; Paroxetine; Rats; Stress Disorders, Post-Traumatic; Taurine | 2021 |
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
Topics: Adult; Anticonvulsants; Female; Fluoxetine; Humans; Male; Medical Records; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2018 |
Prospective Study of the Effectiveness of Paroxetine on the Onset of Posttraumatic Stress Disorder, Depression, and Health and Functional Outcomes After Trauma.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Quality of Life; Recovery of Function; Stress Disorders, Post-Traumatic; Trauma Centers; Treatment Outcome; Young Adult | 2019 |
Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cytokines; Disease Models, Animal; Fear; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Paroxetine; Receptor, Serotonin, 5-HT2C; RNA Editing; RNA, Messenger; Signal Transduction; Stress Disorders, Post-Traumatic | 2019 |
What kind of diagnosis in a case of mobbing: post-traumatic stress disorder or adjustment disorder?
Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Crowding; Diagnosis, Differential; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Middle Aged; Paroxetine; Pregabalin; Stress Disorders, Post-Traumatic | 2013 |
Amygdala deep brain stimulation is superior to paroxetine treatment in a rat model of posttraumatic stress disorder.
Topics: Amygdala; Animals; Deep Brain Stimulation; Disease Models, Animal; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2013 |
Risperidone ameliorates post-traumatic stress disorder-like symptoms in modified stress re-stress model.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Immobility Response, Tonic; Male; Maze Learning; Paroxetine; Rats; Risperidone; Stress Disorders, Post-Traumatic; Swimming; Time Factors | 2013 |
Suicide attempt and externalizing behaviours in posttraumatic stress disorder (PTSD): possible role of the activating effect of antidepressants.
Topics: Adult; Female; Humans; Mental Disorders; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Suicide, Attempted | 2015 |
The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
Topics: Animals; Brain; Cycloserine; Disease Models, Animal; Electroencephalography; Electroshock; Hydrocarbons, Halogenated; Male; Mice; Paroxetine; Receptors, Corticotropin-Releasing Hormone; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Stress, Psychological; Thiazines; Wakefulness | 2015 |
Effects of paroxetine on PTSD-like symptoms in mice.
Topics: Animals; Anxiety; Avoidance Learning; Electroshock; Fear; Male; Mice; Paroxetine; Stress Disorders, Post-Traumatic; Treatment Outcome | 2015 |
Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Apoptosis; Brain; Corticosterone; Male; Maze Learning; Mitochondria; Paroxetine; Rats; Risperidone; Stress Disorders, Post-Traumatic | 2015 |
Emotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change.
Topics: Adult; Afghan Campaign 2001-; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition; Emotions; Humans; Iraq War, 2003-2011; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Oxygen; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans; War Exposure | 2016 |
cis-3-Hexenol and trans-2-hexenal mixture prevents development of PTSD-like phenotype in rats.
Topics: Aldehydes; Animals; Conditioning, Psychological; Disease Models, Animal; Drug Evaluation, Preclinical; Exploratory Behavior; Extinction, Psychological; Fear; Fenclonine; Hexanols; Male; Motor Activity; Paroxetine; Phenotype; Prepulse Inhibition; Psychotropic Drugs; Random Allocation; Rats, Sprague-Dawley; Reflex, Startle; Stress Disorders, Post-Traumatic | 2016 |
Paroxetine treatment, following behavioral suppression of PTSD-like symptoms in mice, prevents relapse by activating the infralimbic cortex.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Cerebral Cortex; Conditioning, Classical; Cues; Disease Models, Animal; Electroshock; Freezing Reaction, Cataleptic; Male; Maze Learning; Mice; Oncogene Proteins v-fos; Paroxetine; Recurrence; Stress Disorders, Post-Traumatic; Tetrodotoxin; Time Factors | 2016 |
Severe, multimodal stress exposure induces PTSD-like characteristics in a mouse model of single prolonged stress.
Topics: Animals; Behavior, Animal; Conditioning, Classical; Corticosterone; Cues; Disease Models, Animal; Extinction, Psychological; Fear; Glutamic Acid; Hippocampus; Male; Mice; Mice, Inbred C57BL; Paroxetine; Prefrontal Cortex; Receptors, Glucocorticoid; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress, Psychological; Swimming | 2016 |
A single prolonged stress paradigm produces enduring impairments in social bonding in monogamous prairie voles.
Topics: Animals; Arvicolinae; Brain; Disease Models, Animal; Exploratory Behavior; Female; Male; Neurons; Oxytocin; Pair Bond; Paroxetine; Receptors, Glucocorticoid; Receptors, Vasopressin; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Supraoptic Nucleus; Time Factors; Tyrosine 3-Monooxygenase | 2016 |
Characteristics of objective daytime sleep among individuals with earthquake-related posttraumatic stress disorder: A pilot community-based polysomnographic and multiple sleep latency test study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; China; Circadian Rhythm; Cross-Sectional Studies; Disasters; Earthquakes; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Polysomnography; Sleep; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Young Adult | 2017 |
A modified single-prolonged stress model for post-traumatic stress disorder.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Fear; Freezing Reaction, Cataleptic; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Stress Disorders, Post-Traumatic; Time Factors | 2008 |
Reproductive neuroscience: biology, environment, and clinical implications in women's mental health.
Topics: Adult; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Mental Disorders; Middle Aged; Paroxetine; Perimenopause; Reproductive Medicine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Social Environment; Stress Disorders, Post-Traumatic | 2008 |
[Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].
Topics: Citalopram; Electromyography; Electrooculography; Humans; Paroxetine; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, REM; Stress Disorders, Post-Traumatic; Wakefulness | 2008 |
Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticotropin-Releasing Hormone; Female; Humans; Insulin-Like Growth Factor I; Interleukin-6; Male; Middle Aged; Paroxetine; Personality Inventory; Psychometrics; Stress Disorders, Post-Traumatic; Substance P; Treatment Outcome | 2011 |
Conditioned fear stress combined with single-prolonged stress: a new PTSD mouse model.
Topics: Animals; Conditioning, Psychological; Disease Models, Animal; Fear; Male; Mice; Paroxetine; Random Allocation; Stress Disorders, Post-Traumatic; Stress, Psychological | 2012 |
Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.
Topics: Adult; Brain Mapping; Case-Control Studies; Female; Hippocampus; Humans; Individuality; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Time; Verbal Learning; Wechsler Scales | 2003 |
Effect of paroxetine on a model of posttraumatic stress disorder in rats.
Topics: Animals; Arousal; Avoidance Learning; Cues; Disease Models, Animal; Electric Stimulation; Male; Motor Activity; Paroxetine; Photic Stimulation; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2004 |
Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder.
Topics: Brain; Cognition; Hippocampus; Humans; Memory; Nervous System; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Verbal Behavior | 2004 |
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2005 |
The auditory startle response in post-traumatic stress disorder.
Topics: Acoustic Stimulation; Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Data Interpretation, Statistical; Electromyography; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Humans; Hypnotics and Sedatives; Male; Middle Aged; Muscle Contraction; Muscle, Skeletal; Oxazepam; Paroxetine; Reflex, Startle; Stress Disorders, Post-Traumatic | 2006 |
Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats.
Topics: Animals; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Ether; Fear; Freezing Reaction, Cataleptic; Male; Motor Activity; Pain Measurement; Pain Threshold; Paroxetine; Rats; Rats, Sprague-Dawley; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Swimming; Vocalization, Animal | 2006 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Paroxetine binding in the blood platelets of post-traumatic stress disorder patients.
Topics: Adult; Blood Platelets; Cells, Cultured; Humans; Male; Middle Aged; Military Personnel; Paroxetine; Serotonin; Stress Disorders, Post-Traumatic; Tritium | 1993 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |